Ad is loading...
VCRQX
Price
$13.59
Change
+$0.09 (+0.67%)
Updated
Nov 15 closing price
VGIRX
Price
$15.08
Change
+$0.11 (+0.73%)
Updated
Nov 15 closing price
Ad is loading...

VCRQX vs VGIRX

Header iconVCRQX vs VGIRX Comparison
Open Charts VCRQX vs VGIRXBanner chart's image
NYLI CBRE Global Infrastructure Class R6
Price$13.59
Change+$0.09 (+0.67%)
VolumeN/A
CapitalizationN/A
Virtus Duff & Phelps Global Infras R6
Price$15.08
Change+$0.11 (+0.73%)
VolumeN/A
CapitalizationN/A
VCRQX vs VGIRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VCRQX vs. VGIRX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VCRQX is a Buy and VGIRX is a Buy.

FUNDAMENTALS
Fundamentals
VCRQX has more cash in the bank: 873M vs. VGIRX (146M). VCRQX pays higher dividends than VGIRX: VCRQX (2.75) vs VGIRX (2.23). VCRQX was incepted earlier than VGIRX: VCRQX (5 years) vs VGIRX (7 years). VCRQX is a more actively managed with annual turnover of: 43.00 vs. VGIRX (26.00). VCRQX has a lower initial minimum investment than VGIRX: VCRQX (0) vs VGIRX (2500000). VCRQX (19.32) and VGIRX (18.57) have marching annual gain over last year.
VCRQXVGIRXVCRQX / VGIRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years7 years-
Gain YTD11.48512.46992%
Front LoadN/AN/A-
Min. Initial Investment02500000-
Min. Initial Investment IRAN/AN/A-
Net Assets873M146M598%
Annual Yield % from dividends2.752.23123%
Returns for 1 year19.3218.57104%
Returns for 3 years11.06-5.23-211%
Returns for 5 yearsN/A3.23-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTBK10.65-0.02
-0.19%
Heritage Commerce Corp
STRT40.64-0.33
-0.81%
STRATTEC SECURITY Corp
AMPH44.61-0.45
-1.00%
Amphastar Pharmaceuticals
MKSI105.48-7.44
-6.59%
MKS Instruments
BDRX3.62-1.24
-25.51%
Biodexa Pharmaceuticals plc